Anzeige
Mehr »
Sonntag, 24.05.2026 - Börsentäglich über 12.000 News
Diese 0,13 €-Aktie besitzt 2 der wichtigsten kritischen Metalle der Welt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire
165 Leser
Artikel bewerten:
(0)

LifeSci Advisors, LLC: LifeSci Advisors Continues Expansion of U.S. Team with Appointment of Daniel Ferry

NEW YORK, 2017-11-07 14:00 CET (GLOBE NEWSWIRE) --
LifeSci Advisors, LLC (the "Company" or "LifeSci"), the leading international
investor relations and corporate communications firm dedicated to the life
sciences sector, today announced the appointment of Daniel Ferry as Managing
Director.  Mr. Ferry will serve as a Relationship Manager and will contribute
to Corporate Access.  He will be based out of LifeSci's Boston office. 

Mr. Ferry joins LifeSci Advisors from Guggenheim Securities, where he served as
a Director in the Boston office. At Guggenheim, Daniel worked across multiple
industries but specialized in connecting healthcare companies with buy-side
investors, venture capitalists, key opinion leaders, sell-side analysts, and
the firm's investment bank.  In his four years at Guggenheim Securities, he
organized numerous non-deal roadshows, collected feedback from investors, and
helped shape investor outreach strategies.  Prior to joining Guggenheim, Daniel
worked at Lazard Capital Markets, where he grew middle markets revenue by over
400% and participated in many successful healthcare company financings.  He
began his career with Fidelity Investments. Over the course of his twenty-year
career in financial services, Daniel has developed long-standing relationships
with the healthcare investment community. He received a BS in Finance from the
University of Southern California.  He also holds Series 7 and Series 63
licenses. 

Passionate about the rights of people with disabilities, Daniel is active in a
number of nonprofit organizations, including Newton Athletes Unlimited and the
Massachusetts Down Syndrome Congress, for whom he ran the Boston Marathon in
2011. Daniel currently resides with his wife, Norah, and their three children,
Gwen, Charlie, and Willa, in Newton, Massachusetts. 

"We are pleased to add Daniel to our growing team," said Andrew McDonald, CEO
and Founding Partner of LifeSci Advisors. "While serving as Director of Equity
Sales at Guggenheim, Daniel ensured his life science clients were meeting with
the right investors across the globe.  With more than 20 years of experience in
the healthcare banking business, Daniel is well-connected within the healthcare
investment community.  As a growing international investor and corporate
communications firm, we continue to attract top talent, like Daniel, to provide
counsel and support our client companies.  We look forward to leveraging
Daniel's expertise and expansive network of investor contacts." 

"I am excited to be a part of the largest and growing life sciences investor
relations firm," said Mr. Ferry.  "LifeSci has established itself as a leader
in the healthcare industry, both among companies and within the investment
community. I look forward to a successful and rewarding career as a member of
the LifeSci team." 

LifeSci has offices in Israel, UK and Switzerland, as well as multiple North
American locations. The firm's capabilities include Corporate Access, Equity
Research, Corporate Communications, KOL Events, Corporate Governance, Capital
Markets Solutions, and Public Relations. 

LifeSci Advisors, LLC (www.lifesciadvisors.com) is the largest investor
relations consultancy in the life sciences industry, founded to provide
companies with a multi-faceted approach to investor communications and
outreach. With a global focus and reach, the firm provides the highest quality
service for its clients through its deep sector specialization. LifeSci's team
of MDs and PhDs enables the firm to better understand clients' R&D, regulatory
and commercial strategies, and its team of financial services, investor
relations and public relations specialists helps clients effectively
communicate to the marketplace. This combination of life sciences, financial
services, and investor relations competencies allows LifeSci Advisors to
provide an invaluable and unique service offering to clients. 

LifeSci Partners (www.lifescipartners.com) is the leading provider of
consulting services in the areas of investor relations, public relations,
corporate communications and capital markets advisory. Combining deep domain
expertise in the life sciences with decades of experience in capital markets
and public relations, LifeSci Partners delivers unparalleled services to life
sciences companies globally. 

         For further information, please contact:
         
         Andrew McDonald
         CEO, Founding Partner
         LifeSci Advisors, LLC
         (646) 597-6987
© 2017 GlobeNewswire
Vergessen Sie Gold, Silber und Öl: Nächste Megarallye startet!
Die Märkte feiern neue Rekorde – doch im Hintergrund braut sich eine Entwicklung zusammen, die alles verändern könnte. Die anhaltende Sperrung der Straße von Hormus sorgt laut IEA für eine der größten Energiekrisen aller Zeiten. Gleichzeitig schießen die Preise für Düngemittel und Agrarrohstoffe bereits nach oben.

Damit droht ein perfekter Sturm: steigende Energiepreise, explodierende Produktionskosten und ein möglicher Super-El-Nino, der weltweit Ernten gefährdet. Erste Auswirkungen sind längst sichtbar – Weizen, Soja und Kakao verteuern sich deutlich, während Lebensmittelpreise vor dem nächsten Sprung stehen könnten.

Für Anleger bedeutet das nicht nur Risiken, sondern enorme Chancen. Denn während klassische Märkte unter Druck geraten könnten, entsteht auf den Feldern und Plantagen der nächste große Rohstoffzyklus. Wer sich jetzt richtig positioniert, kann von einer Entwicklung profitieren, die weit über Öl und Metalle hinausgeht.

In unserem aktuellen Spezialreport stellen wir drei Aktien vor, die besonders aussichtsreich sind, um von diesem Trend zu profitieren – solide positioniert, strategisch relevant und mit erheblichem Aufwärtspotenzial.



Jetzt den kostenlosen Report sichern – bevor der Agrar-Boom voll durchschlägt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.